Abridge Adds Yale New Haven Health, Picks Up $150M Investment

As health systems rush to implement generative AI solutions for clinical documentation, startups in the space are competing for position. One of those providers, Pittsburgh-based Abridge, just landed an additional $150 million investment and a major new customer in Yale New Haven Health System.

The new funding comes just four months after Abridge raised $30 million in a Series B investment round.

Abridge said the agreement with Yale New Haven Health System, Connecticut’s largest and most comprehensive health care system, will give thousands of physicians access to Abridge for clinical documentation. Yale New Haven Health has selected Abridge as its generative AI partner in this area of ​​environmental listening. Initial implementation will focus on reducing the cognitive load of clinical documentation, allowing clinicians to spend more time face-to-face with patients rather than with computers.

In August 2023, Healthcare innovation interviewed Alistair Erskine, MD, MBA, chief information and digital officer at Atlanta-based Emory Healthcare, about why his organization signed an enterprise-level agreement to make Abridge’s Epic integrated note-taking solution available to Emory doctors for the next three years. .

“What surprised me about Abridge, and what piqued my curiosity, is that its technology is pervasive. I don’t need to wait until he tells me, ‘Okay, now we’re good for cardiologists.’ Right now, I have 20 doctors using it, in all different specialties, and I’m getting the same positive feedback from all of them,” Erksine said. (Since that interview, Emory’s Abridge user base has grown to more than 500 physicians.)

Abridge said its “Linked Evidence” feature maps any highlighted region within a summary to the supporting evidence in the source transcript (and therefore the underlying audio). The company also said it is developing novel ways to personalize notes, integrate them more deeply into the EHR and provide physicians with valuable information after the visit.

The Series C investment was led by Lightspeed Venture Partners, who will also join the board. Other new and existing investors include co-lead Redpoint Ventures, supported by IVP, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Mass General Brigham Artificial Intelligence and Digital Innovation Fund (AIDIF), Kaiser Permanente Ventures and CVS. Health ventures.

We will be happy to hear your thoughts

Leave a reply

Register New Account
Compare items
  • Total (0)
Shopping cart